The OS of NR2F1 high triple- negative and ER-positive/HER2-negative subtypes were associated with better survival in GSE96058, and DSS of NR2F1 high HER2-positive subtypes was associated with worse survival in METABRIC.
The authors state “We demonstrated that the expression of NR2F1, RARB, and TGFB1 genes are higher in previously established dormant cells (D2OR murine breast cancer cells [44] compared to the proliferative cells (D2A1 cells) in both 2D and 3D cultures (Figure 1A, all p < 0.02).” This is not true for NR2F1 in 2D. Please correct.